Literature DB >> 3939534

Heterogeneity and complementation analysis of fibroblasts from vitamin B6 responsive and non-responsive patients with gyrate atrophy of the choroid and retina.

M K Wirtz, N G Kennaway, R G Weleber.   

Abstract

Fibroblasts from four pyridoxine responsive and three non-responsive patients with gyrate atrophy of the choroid and retina have been examined. Responsive patients had higher activity of ornithine ketoacid transaminase (OKT) in cell homogenates and greater incorporation of radioactivity from 14C-ornithine into protein in cultured cells in situ compared to non-responsive patients. Complementation analysis of the cells from these seven patients was performed, based on the ratio of incorporation of 14C/3H into protein in fused cells incubated in 14C-ornithine and 3H-leucine. Lack of positive complementation in these crosses suggests that pyridoxine responsive and non-responsive patients with gyrate atrophy represent different allelic mutations of the same genetic locus coding for OKT.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3939534     DOI: 10.1007/bf01801668

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  14 in total

1.  Studies on the structure of rat liver ornithine aminotransferase.

Authors:  T Shiotani; Y Sanada; N Katunuma
Journal:  J Biochem       Date:  1977-06       Impact factor: 3.387

2.  Defective ornithine metabolism in the syndrome of hyperornithinaemia, hyperammonaemia and homocitrullinuria.

Authors:  V E Shih; R Mandell; A Herzfeld
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

3.  Clinical and biochemical heterogeneity in gyrate atrophy.

Authors:  M I Kaiser-Kupfer; D Valle; A J Bron
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

4.  Gyrate atrophy with hyperornithinaemia: different types of responsiveness to vitamin B6.

Authors:  S Hayasaka; T Saito; H Nakajima; Y Takaku; T Shiono; K Mizuno; K Ohmura; K Tada
Journal:  Br J Ophthalmol       Date:  1981-07       Impact factor: 4.638

5.  Gyrate atrophy of the choroid and retina: clinical and biochemical heterogeneity and response to vitamin B6.

Authors:  R G Weleber; M K Wirtz; N G Kennaway
Journal:  Birth Defects Orig Artic Ser       Date:  1982

6.  Ornithine ketoacid transaminase deficiency in gyrate atrophy of the choroid and retina.

Authors:  V E Shih; E L Berson; R Mandell; S Y Schmidt
Journal:  Am J Hum Genet       Date:  1978-03       Impact factor: 11.025

7.  Ocular and biochemical abnormalities in gyrate atrophy of the choroid and retina.

Authors:  E L Berson; S Y Schmidt; V E Shih
Journal:  Ophthalmology       Date:  1978-10       Impact factor: 12.079

8.  Decreased transport of ornithine across the inner mitochondrial membrane as a cause of hyperornithinaemia.

Authors:  F A Hommes; C K Ho; R A Roesel; M E Coryell; B A Gordon
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

9.  Clinical trial of vitamin B6 for gyrate atrophy of the choroid and retina.

Authors:  R G Weleber; N G Kennaway
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

10.  Complementation analysis in fibroblasts from eight patients with clinically different forms of citrullinaemia.

Authors:  N G Kennaway; H C Curtis
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

View more
  2 in total

1.  Gyrate atrophy of the choroid and retina: characterization of mutant ornithine aminotransferase and mechanism of response to vitamin B6.

Authors:  N G Kennaway; L Stankova; M K Wirtz; R G Weleber
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

2.  Metabolic follow-up of a Croatian patient with gyrate atrophy and a new mutation in the OAT gene: a case report.

Authors:  Marija Zekušić; Ana Škaričić; Ksenija Fumić; Dunja Rogić; Tamara Žigman; Danijela Petković Ramadža; Nenad Vukojević; Véronique Rüfenacht; Valentina Uroić; Ivo Barić
Journal:  Biochem Med (Zagreb)       Date:  2018-10-15       Impact factor: 2.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.